Literature DB >> 22451679

Transforming growth factor-β1 regulates Cdk5 activity in primary sensory neurons.

Elias Utreras1, Jason Keller, Anita Terse, Michaela Prochazkova, Michael J Iadarola, Ashok B Kulkarni.   

Abstract

In addition to many important roles for Cdk5 in brain development and synaptic function, we reported previously that Cdk5 regulates inflammatory pain signaling, partly through phosphorylation of transient receptor potential vanilloid 1 (TRPV1), an important Na(+)/Ca(2+) channel expressed in primary nociceptive afferent nerves. Because TGF-β regulates inflammatory processes and its receptor is expressed in TRPV1-positive afferents, we studied the cross-talk between these two pathways in sensory neurons during experimental peripheral inflammation. We demonstrate that TGF-β1 increases transcription and protein levels of the Cdk5 co-activator p35 through ERK1/2, resulting in an increase in Cdk5 activity in rat B104 neuroblastoma cells. Additionally, TGF-β1 enhances the capsaicin-induced Ca(2+) influx in cultured primary neurons from dorsal root ganglia (DRG). Importantly, Cdk5 activity was reduced in the trigeminal ganglia and DRG of 14-day-old TGF-β1 knock-out mice, resulting in reduced Cdk5-dependent phosphorylation of TRPV1. The decreased Cdk5 activity is associated with attenuated thermal hyperalgesia in TGF-β1 receptor conditional knock-out mice, where TGF-β signaling is significantly reduced in trigeminal ganglia and DRG. Collectively, our results indicate that active cross-talk between the TGF-β and Cdk5 pathways contributes to inflammatory pain signaling.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22451679      PMCID: PMC3351291          DOI: 10.1074/jbc.M111.329979

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain.

Authors:  Paula Grammas; Roma Ovase
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

2.  Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling.

Authors:  Satoru Takahashi; Toshio Ohshima; Andrew Cho; Taduru Sreenath; Michael J Iadarola; Harish C Pant; Yong Kim; Angus C Nairn; Roscoe O Brady; Paul Greengard; Ashok B Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

3.  Transforming growth factor beta1-regulated cell proliferation and expression of neural cell adhesion molecule in B104 neuroblastoma cells: differential effects of ethanol.

Authors:  J Luo; M W Miller
Journal:  J Neurochem       Date:  1999-06       Impact factor: 5.372

4.  Molecular Roles of Cdk5 in Pain Signaling.

Authors:  Elias Utreras; Akira Futatsugi; Tej Kumar Pareek; Ashok B Kulkarni
Journal:  Drug Discov Today Ther Strateg       Date:  2009-09

5.  p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment.

Authors:  J Ko; S Humbert; R T Bronson; S Takahashi; A B Kulkarni; E Li; L H Tsai
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

Review 6.  A decade of CDK5.

Authors:  R Dhavan; L H Tsai
Journal:  Nat Rev Mol Cell Biol       Date:  2001-10       Impact factor: 94.444

Review 7.  Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer's.

Authors:  Tony Wyss-Coray
Journal:  Curr Alzheimer Res       Date:  2006-07       Impact factor: 3.498

8.  Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain.

Authors:  Patrick T Ronaldson; Kristin M Demarco; Lucy Sanchez-Covarrubias; Christine M Solinsky; Thomas P Davis
Journal:  J Cereb Blood Flow Metab       Date:  2009-03-25       Impact factor: 6.200

9.  BAMBI (bone morphogenetic protein and activin membrane-bound inhibitor) reveals the involvement of the transforming growth factor-beta family in pain modulation.

Authors:  Mónica Tramullas; Aquilino Lantero; Alvaro Díaz; Néstor Morchón; David Merino; Ana Villar; Dirk Buscher; Ramón Merino; Juan M Hurlé; Juan Carlos Izpisúa-Belmonte; María A Hurlé
Journal:  J Neurosci       Date:  2010-01-27       Impact factor: 6.167

Review 10.  Transforming growth factor-beta-induced regulatory T cells referee inflammatory and autoimmune diseases.

Authors:  Sharon M Wahl; Wanjun Chen
Journal:  Arthritis Res Ther       Date:  2005-01-24       Impact factor: 5.156

View more
  23 in total

1.  Cdk5 inhibitor roscovitine alleviates neuropathic pain in the dorsal root ganglia by downregulating N-methyl-D-aspartate receptor subunit 2A.

Authors:  Lei Yang; Xiaoping Gu; Wei Zhang; Juan Zhang; Zhengliang Ma
Journal:  Neurol Sci       Date:  2014-09       Impact factor: 3.307

2.  Pain improvement in Camurati-Engelmann disease after anti-TNFα therapy.

Authors:  Sónia Moreira; Bernardo Cunha; Nelson Pedro Jesus; Lèlita Santos
Journal:  BMJ Case Rep       Date:  2017-11-28

3.  Cdk5 regulates Rap1 activity.

Authors:  Elias Utreras; Daniel Henriquez; Erick Contreras-Vallejos; Cristina Olmos; Alex Di Genova; Alejandro Maass; Ashok B Kulkarni; Christian Gonzalez-Billault
Journal:  Neurochem Int       Date:  2013-02-13       Impact factor: 3.921

4.  Neuronal Transforming Growth Factor beta Signaling via SMAD3 Contributes to Pain in Animal Models of Chronic Pancreatitis.

Authors:  Liansheng Liu; Yaohui Zhu; Michaël Noë; Qian Li; Pankaj Jay Pasricha
Journal:  Gastroenterology       Date:  2018-03-02       Impact factor: 22.682

5.  Visualization of trigeminal ganglion sensory neuronal signaling regulated by Cdk5.

Authors:  Minghan Hu; Andrew D Doyle; Kenneth M Yamada; Ashok B Kulkarni
Journal:  Cell Rep       Date:  2022-03-08       Impact factor: 9.423

6.  Molecular signatures of mouse TRPV1-lineage neurons revealed by RNA-Seq transcriptome analysis.

Authors:  Samridhi C Goswami; Santosh K Mishra; Dragan Maric; Krisztian Kaszas; Gian Luigi Gonnella; Samuel J Clokie; Hal D Kominsky; Jacklyn R Gross; Jason M Keller; Andrew J Mannes; Mark A Hoon; Michael J Iadarola
Journal:  J Pain       Date:  2014-10-02       Impact factor: 5.820

7.  Condition-specific role of colonic inflammatory molecules in persistent functional colorectal hypersensitivity in the mouse.

Authors:  J-H La; G F Gebhart
Journal:  Neurogastroenterol Motil       Date:  2014-10-13       Impact factor: 3.598

8.  Targeted overexpression of tumor necrosis factor-α increases cyclin-dependent kinase 5 activity and TRPV1-dependent Ca2+ influx in trigeminal neurons.

Authors:  Pablo Rozas; Pablo Lazcano; Ricardo Piña; Andrew Cho; Anita Terse; Maria Pertusa; Rodolfo Madrid; Christian Gonzalez-Billault; Ashok B Kulkarni; Elias Utreras
Journal:  Pain       Date:  2016-06       Impact factor: 7.926

9.  Cyclin-dependent kinase 5 modulates the P2X2a receptor channel gating through phosphorylation of C-terminal threonine 372.

Authors:  Claudio Coddou; Rodrigo Sandoval; Patricio Castro; Pablo Lazcano; Maria José Hevia; Milos Rokic; Bradford Hall; Anita Terse; Christian Gonzalez-Billault; Ashok B Kulkarni; Stanko S Stojilkovic; Elias Utreras
Journal:  Pain       Date:  2017-11       Impact factor: 7.926

10.  TGF-β1 sensitizes TRPV1 through Cdk5 signaling in odontoblast-like cells.

Authors:  Elias Utreras; Michaela Prochazkova; Anita Terse; Jacklyn Gross; Jason Keller; Michael J Iadarola; Ashok B Kulkarni
Journal:  Mol Pain       Date:  2013-05-13       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.